FTC files for injunction against Airborne copycat
This article was originally published in The Tan Sheet
The Federal Trade Commission requests a permanent injunction against supplement firm Improvita Health Products for "engaging in deceptive acts or practices in connection with the advertising, marketing, and sale of the Germ Defense line of products, which are purported to prevent, treat, or cure cold and flu," between 2005 and 2008, according to a complaint filed April 15 in the U.S. District Court for the Northern District of Ohio. FTC alleges the Cleveland-based firm's products "expressly or by implication" make certain unsubstantiated prevention and treatment claims. In its advertising the firm likens the products to Airborne, which also faced FTC scrutiny for making unsubstantiated claims (1"The Tan Sheet" Aug. 18, 2008, p. 8)
You may also be interested in...
Under a settlement with the Federal Trade Commission announced Aug. 14, the maker of Airborne dietary supplement products must cease unsubstantiated health-related claims and contribute up to $6.5 million to an existing consumer redress fund
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.